Clinical Trial Update: A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase II multicenter randomized trial is evaluating sintilimab plus SOX versus SOX alone as adjuvant therapy for PD-L1-positive, stage pN3 gastric cancer; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Sintilimab (sintilimab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: RECRUITING